MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Uncover how genetic testing for FFEVF2 identifies NPRL3 variants, offering diagnostic clarity, personalized treatments, and key insights for family planning in epilepsy.
Explore the genetic basis of Familial Focal Epilepsy, Variable Foci 3, focusing on NPRL3 mutations. Learn how genetic testing aids in diagnosis and personalized treatment.
Explore how genetic testing aids in diagnosing familial isolated hyperparathyroidism by identifying mutations, distinguishing conditions, and informing treatment.
Unlock insights into Fanconi Anemia Group R with genetic testing. Discover how it aids in diagnosis, personalized treatment, family planning, and research.
Unlock the power of genetic testing for Fanconi Anemia Group U. Achieve early diagnosis, informed family planning, and personalized treatments effectively.
Explore the role of genetic testing in diagnosing Fanconi Anemia Group V. Learn about accurate diagnosis, personalized treatment, and family planning benefits.
Explore how genetic testing aids in diagnosing Frontometaphyseal Dysplasia 2, a rare bone disorder, by identifying specific FLNA gene mutations for precise care.
Unlock the potential of genetic testing for early diagnosis and personalized treatment of Primary Congenital Glaucoma. Explore genetic insights and family planning options.